According to GeneDx Holdings's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 12.5. At the end of 2024 the company had a P/S ratio of 4.31.
Year | P/S ratio | Change |
---|---|---|
2024 | 4.31 | 1127.41% |
2023 | 0.3514 | -19.17% |
2022 | 0.4348 | -91.43% |
2021 | 5.07 |